Safety and immunogenicity of a nicotine conjugate vaccine in current smokers - Wikidata - awgldk - TriplyDB

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

http://www.wikidata.org/entity/Q28284686

about

Future pharmacological treatments for substance use disorders Nicotine vaccines for smoking cessation Nicotine vaccines for smoking cessation Mechanistic insights into nicotine withdrawal.New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Symbiotic relationship of pharmacogenetics and drugs of abuse.Immunogenicity of a promiscuous T cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten Treatment of nicotine addiction: present therapeutic options and pipeline developments.A vaccine against nicotine for smoking cessation: a randomized controlled trial Vaccines against stimulants: cocaine and MA New directions in nicotine vaccine design and use.Nicotine vaccines: will smokers take a shot at quitting?Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation.Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial Impact of distinct chemical structures for the development of a methamphetamine vaccine Targeting nicotine addiction: the possibility of a therapeutic vaccine.Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats Therapeutic options and challenges for substances of abuse.Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.Neuropharmacology and potential efficacy of new treatments for tobacco dependence.Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.Preventing sin: the ethics of vaccines against smoking.Tobacco addiction.Current and emerging pharmacotherapies for treating tobacco dependence.A vaccine against methamphetamine attenuates its behavioral effects in mice.Vaccines in the Treatment of Substance Abuse Anti-(+)-methamphetamine monoclonal antibody antagonists designed to prevent the progression of human diseases of addiction Dynamic vaccine blocks relapse to compulsive intake of heroin.Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.Substance abuse vaccines.

P2860

Q22242633-4AEC8CB8-F2F1-4AB5-8E22-AADB7331C4BF Q24201422-CB512C7E-F776-4C81-A51F-B1F77DA176E6 Q24243661-33AA908A-62D2-4552-9C1A-23194FBF3FD7 Q27687645-1A6A4DE9-0CCD-45EE-B7E1-502AB5C4DD14 Q28277165-F082E974-C7B2-4BE8-A151-97A53054D48D Q28476270-8B3133A1-DEC0-4706-8726-AF120B408004 Q28483992-90E29720-0C28-49A4-9E7E-D79A158AD696 Q30398847-BDBA9693-A43F-4251-90BA-832733C219B8 Q33346321-99B58925-54A9-4EBA-AFEA-AD2583284977 Q33582086-2D8A267A-84EC-4DC8-9C09-7FA2BDC77A53 Q33719424-7E197B99-1226-421C-91C5-A4BD216EB1CA Q33759617-51534A1F-C615-446E-B3AA-D614AE65C5BD Q33883669-A8CA2C9F-38E4-4E55-99E2-C175933263EB Q33932923-373DE31C-8ED1-4DDC-B891-483689045C2A Q34033200-332FB79D-DEF4-42C1-A4C0-6FC3D68DB5D8 Q34145173-71F731D2-78DD-48B4-ADB5-DCE465786425 Q34157674-8FCE684A-2A22-4A8B-B7E3-E7A19FC4029C Q34235714-E591F44C-126B-47E5-9DAF-B72B43D5691F Q34329011-CC15E3C8-4375-4B3A-A095-24F321F417D9 Q34502208-E969F130-87AE-43C1-B7A9-48CD25D906B4 Q34956542-C46E2936-FC66-4C27-B675-98B83C82D312 Q34987300-59653BE1-6699-4F4A-B06F-96219337C8DF Q35061547-B4CE34E9-1829-402D-9DDC-94764BF58DB9 Q35120379-65995DBA-31FC-4B9E-9F74-34C9039C9AB4 Q35163178-4B3D0368-396D-45B2-A8EA-DB6BF2B745AE Q35224297-747F6239-7EB3-419F-9627-E957ABC85D1D Q35454891-13F9D2A5-A27C-454A-B5D1-E04CA481CDF0 Q35476326-DD02D28B-969F-46F8-8A55-0D4600577598 Q36278801-57F077A3-91BC-4570-B721-A52097EA50BE Q36376434-DE408A0C-FA7A-4CDA-B7FF-C7F1FE1F3276 Q36439191-18BC0B6B-5645-4031-9366-1D3864E896F3 Q36444761-482BFE70-CBAD-4D71-B693-374FA47F5C56 Q36519493-EAC698C9-7517-4215-8756-D5FD506FF9A2 Q36580581-B1D113B4-E50D-4725-B9BF-3E076EFDA022 Q36586100-A0F5026D-07CC-4FB2-BE55-7853CB094AE5 Q36655861-A6072A70-D348-4298-9087-8F5E7DE1C604 Q36838980-43FC94C7-E9FE-4194-A8CD-6390993B6270 Q36895574-66C1B848-5ED6-4D6F-935F-0C284683C8C6 Q36945794-568542C1-6EB5-4214-8769-B8A292CA7730 Q36983386-D39B64FA-986B-4D5E-B24C-8E6A33B22C2C

P2860

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

http://www.wikidata.org/entity/Q28284686

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@ast

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@en

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@nl

type

label

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@ast

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@en

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@nl

prefLabel

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@ast

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@en

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@nl

P1433

Q28284686-BF77794D-9070-4FE1-AA7D-C56A97242E72

P1476

Q28284686-F4D48367-DFDF-4D1C-809C-60C6F0457326

P2093

Q28284686-27270C4D-332D-4B53-B775-10E9A0719F9C

Q28284686-294890E7-4CD3-4377-8AA3-E31AF06293D7

Q28284686-6468C9D7-32E0-46E8-9D2C-9B7C2102F7D2

Q28284686-772DD299-B244-433F-8678-98831E20824B

Q28284686-8DD0C075-F20B-4C78-BFDB-36349B52D8EB

Q28284686-91467309-4176-42EB-8A55-35678856428D

Q28284686-AE198473-9562-49D7-A593-0CCD76132D0F

Q28284686-DC205CEE-5F71-4DE5-B618-05EFBC482601

P304

Q28284686-E611476A-7A6A-4E22-A8CF-9897FF3BF22F

P31

Q28284686-1936B345-D7B0-44A1-A058-DB18EF57AA4E

P356

Q28284686-3FD8FF3B-6904-4ECB-8EC0-47CF8421E89F

P407

Q28284686-8C31BF8E-6090-4371-8DFF-AE08EF003464

P433

Q28284686-AD1D1C34-FCD1-4777-8B8D-9D4980953FFE

P478

Q28284686-989E1AC2-5AE3-4EB2-BE4C-4FAC515F22E5

P577

Q28284686-253A67E2-80B8-4BC9-BD98-A5918774DA17

P698

Q28284686-224C4E73-E61E-4886-A05B-AE0E9E492FE2

P356

J.CLPT.2005.08.007

P1433

Clinical Pharmacology & Therapeutics

P1476

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

@en

P2093

Arjen de Vos

http://www.w3.org/2001/XMLSchema#string

Dorothy K Hatsukami

http://www.w3.org/2001/XMLSchema#string

Douglas Jorenby

http://www.w3.org/2001/XMLSchema#string

Gary Horwith

http://www.w3.org/2001/XMLSchema#string

Joseph Koopmeiners

http://www.w3.org/2001/XMLSchema#string

Michael Fiore

http://www.w3.org/2001/XMLSchema#string

Paul R Pentel

http://www.w3.org/2001/XMLSchema#string

Stephen Rennard

http://www.w3.org/2001/XMLSchema#string

P304

456-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLPT.2005.08.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16321612

http://www.w3.org/2001/XMLSchema#string